The data presented suggest that a potentially interesting therapeutic strategy to improve the outcome of necrotising pneumonia, and notably to control leukopenia, could be to target and inhibit leucocidin receptors, in particular C5aR. This evidence concerns the gene C5AR1 and pneumonia.